MIRM
Mirum Pharmaceuticals Inc

1,608
Mkt Cap
$3.63B
Volume
3.86M
52W High
$79.95
52W Low
$36.88
PE Ratio
-90.21
MIRM Fundamentals
Price
$77.74
Prev Close
$70.28
Open
$70.76
50D MA
$70.48
Beta
0.75
Avg. Volume
606,806.05
EPS (Annual)
-$1.85
P/B
13.66
Rev/Employee
$1.05M
Loading...
Loading...
News
all
press releases
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 52-Week High Following Analyst Upgrade
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 52-Week High After Analyst Upgrade...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Up 8.9% Following Analyst Upgrade
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Up 8.9% Following Analyst Upgrade...
MarketBeat·19h ago
News Placeholder
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $140.00
Citizens Jmp increased their price target on shares of Mirum Pharmaceuticals from $95.00 to $140.00 and gave the company a "market outperform" rating in a report on Friday...
MarketBeat·21h ago
News Placeholder
Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a subscription agreement with entities associated with TCGX, an institutional...
Business Wire·21h ago
News Placeholder
Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026?
Mirum's Livmarli sales surge 70% in the first nine months of 2025. Expanding approvals and commercialization are set to fuel revenue momentum into 2026.
Zacks·2d ago
News Placeholder
Stifel Nicolaus Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price
Stifel Nicolaus upped their target price on shares of Mirum Pharmaceuticals from $92.00 to $98.00 and gave the company a "buy" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Eventide Asset Management LLC Has $134.22 Million Holdings in Mirum Pharmaceuticals, Inc. $MIRM
Eventide Asset Management LLC raised its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 4.4% during the second quarter, according to its most recent filing with the Securities...
MarketBeat·7d ago
News Placeholder
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by BVF Inc. IL
BVF Inc. IL lessened its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 1.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional...
MarketBeat·7d ago
News Placeholder
Boone Capital Management LLC Has $32.64 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRM
Boone Capital Management LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.3% during the second quarter, according to its most recent filing with the...
MarketBeat·7d ago
News Placeholder
What is HC Wainwright's Forecast for MIRM FY2025 Earnings?
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Mirum Pharmaceuticals in a note issued to investors on Tuesday...
MarketBeat·9d ago
<
1
2
...
>

Latest MIRM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.